Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata
Clinical trial NCT03811912 · COMPLETED
Trial details
- NCT number
- NCT03811912
- Sponsor
- Concert Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-21
- Primary completion
- 2019-11-21
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.